Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Med Genet ; 66(5): 104730, 2023 May.
Article in English | MEDLINE | ID: mdl-36801247

ABSTRACT

Whole exome sequencing is recommended as the first tier test for neurodevelopmental disorders (NDDs) with trio being an ideal option for the detection of de novo variants. Cost constraints have led to adoption of sequential testing i.e. proband-only whole exome followed by targeted testing of parents. The reported diagnostic yield for proband exome approach ranges between 31 and 53%. Typically, these study designs have aptly incorporated targeted parental segregation before concluding a genetic diagnosis to be confirmed. The reported estimates however do not accurately reflect the yield of proband only standalone whole -exome, a question commonly posed to the referring clinician in self pay medical systems like India. To assess the utility of standalone proband exome (without follow up targeted parental testing), we retrospectively evaluated 403 cases of neurodevelopmental disorders referred for proband-only whole exome sequencing at Neuberg Centre for Genomic Medicine (NCGM), Ahmedabad during the period of January 2019 and December 2021. A diagnosis was considered confirmed only upon the detection of Pathogenic/Likely Pathogenic variants in concordance with patient's phenotype as well as established inheritance pattern. Targeted parental/familial segregation analysis was recommended as a follow up test where applicable. The diagnostic yield of the proband-only standalone whole exome was 31.5%. Only 20 families submitted samples for follow up targeted testing, and a genetic diagnosis was confirmed in twelve cases increasing the yield to 34.5%. To understand factors leading to poor uptake of sequential parental testing, we focused on cases where an ultra-rare variant was detected in hitherto described de novo dominant neurodevelopmental disorder. A total of 40 novel variants in genes associated with de novo autosomal dominant disorders could not be reclassified as parental segregation was denied. Semi-structured telephonic interviews were conducted upon informed consent to comprehend reasons for denial. Major factors influencing decision making included lack of definitive cure in the detected disorders; especially when couples not planning further conception and financial constraints to fund further targeted testing. Our study thus depicts the utility and challenges of proband-only exome approach and highlights the need for larger studies to understand factors influencing decision making in sequential testing.


Subject(s)
Neurodevelopmental Disorders , Resource-Limited Settings , Humans , Child , Exome Sequencing , Retrospective Studies , Neurodevelopmental Disorders/diagnosis , Neurodevelopmental Disorders/genetics , Parents
2.
Clin Dysmorphol ; 18(2): 85-89, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19305192

ABSTRACT

Pachydermoperiostosis is known to occur in three distinct forms: complete, incomplete, and form fruste. We report four patients with clubbing and a cylindrical appearance of lower legs without pachydermia and periostosis. We believe that this represents a milder, but distinct subgroup of pachydermoperiostosis. One family showed probable autosomal recessive inheritance.


Subject(s)
Osteoarthropathy, Primary Hypertrophic/diagnosis , Osteoarthropathy, Primary Hypertrophic/genetics , Adolescent , Adult , Female , Humans , Male , Osteoarthropathy, Primary Hypertrophic/diagnostic imaging , Pedigree , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...